Tag Archives: pancreatic cancer

A 2012 article reported chlamydia trachoma damages the cell wall membranes, and the PARP mechanism for normal cell death (apoptosis)—a hallmark of cancer.  PARP inhibitors are effective in treating fast growing and aggressive tumors that thrive in a low oxygen environment—the tumors most resistant to traditional cancer therapy. PARP inhibitors are being used in breast, ovarian, epithelial ovarian, fallopian tube, and peritoneal cancer; and are being studied in colorectal, prostate, and non-small cell lung cancer, and in melanoma. In 2018,…..

Read more